Genomes and Genes

Species

Samira Yadegari

Summary

Affiliation: Tehran University of Medical Sciences
Location: Tehran, Iran
Publications:
1.Idiopathic (primary) generalized epilepsy. Traditional versus new antiepileptic drugs.

Yadegari S, Bahrami P.

Neurosciences (Riyadh). 2013 Apr;18(2):117-21.

PMID:[PubMed - in process]

Select item
2.Cognitive impairments in patients with cerebrovascular risk factors: A comparison of Mini Mental Status Exam and Montreal Cognitive Assessment.

Sikaroodi H, Yadegari S, Miri SR.

Clin Neurol Neurosurg. 2013 Jan 2. doi:pii: S0303-8467(12)00604-X. 10.1016/j.clineuro.2012.11.026. [Epub ahead of print]

PMID:[PubMed - as supplied by publisher]

Select item
3.Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study.

Bonab MM, Sahraian MA, Aghsaie A, Karvigh SA, Hosseinian SM, Nikbin B, Lotfi J, Khorramnia S, Motamed MR, Togha M, Harirchian MH, Moghadam NB, Alikhani K, Yadegari S, Jafarian S, Gheini MR.

Curr Stem Cell Res Ther. 2012 Nov;7(6):407-14.

PMID:[PubMed - in process]

Select item
4.Protracted disease course after deafness in a man with Brown-Vialetto-Van Laere syndrome.

Yadegari S, Razmjoo K, Nafissi S.

Neurosciences (Riyadh). 2012 Jul;17(3):253-5.

PMID:[PubMed - indexed for MEDLINE]

Select item
5.Four novel C20orf54 mutations identified in Brown-Vialetto-Van Laere syndrome patients.

Dezfouli MA, Yadegari S, Nafissi S, Elahi E.

J Hum Genet. 2012 Sep;57(9):613-7. doi: 10.1038/jhg.2012.70. Epub 2012 Jun 21.

PMID:[PubMed - indexed for MEDLINE]

Publications

  1. Dezfouli M, Yadegari S, Nafissi S, Elahi E. Four novel C20orf54 mutations identified in Brown-Vialetto-Van Laere syndrome patients. J Hum Genet. 2012;57:613-7 pubmed publisher
    ..The causative nucleotide variations were not observed in 200 control individuals. One of the patients harbored compound heterozygous mutations, but only one mutated allele was observed in each of the two remaining patients. ..
  2. Yadegari S, Razmjoo K, Nafissi S. Protracted disease course after deafness in a man with Brown-Vialetto-Van Laere syndrome. Neurosciences (Riyadh). 2012;17:253-5 pubmed
    ..Six years later, he had gradual worsening and death. Along with potential new developing therapeutic options, this case emphasizes considering the diagnosis of BVVLS especially after a long period of stability, even in men. ..
  3. Bonab M, Sahraian M, Aghsaie A, Karvigh S, Hosseinian S, Nikbin B, et al. Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study. Curr Stem Cell Res Ther. 2012;7:407-14 pubmed
    ..Repeating the study with a larger sample size, booster injections and longer follow-up using a controlled study design is advised. ..
  4. Sikaroodi H, Yadegari S, Miri S. Cognitive impairments in patients with cerebrovascular risk factors: a comparison of Mini Mental Status Exam and Montreal Cognitive Assessment. Clin Neurol Neurosurg. 2013;115:1276-80 pubmed publisher
    ..MoCA may be superior to MMSE in early detection of cognitive decline in patients with vascular risk factors. ..
  5. Yadegari S, Bahrami P. Idiopathic (primary) generalized epilepsy. Traditional versus new antiepileptic drugs. Neurosciences (Riyadh). 2013;18:117-21 pubmed
    ..In the proper management of IGE, neurologists should consider the predominant seizure type, patient gender, co-morbidities, and antiepileptic drugs that may aggravate a specific seizure type. ..
  6. Yadegari S. Approach to a patient with blepharoptosis. Neurol Sci. 2016;37:1589-96 pubmed publisher
    ..Considering some features, such as involvement of other cranial nerves, extraocular muscle, pupil size and reactivity, and unilateral or bilateral presentation of ptosis, could help to narrow the differential diagnosis. ..

Detail Information

Publications6